Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

196.48
+9.024.81%
Pre-market: 194.84-1.6400-0.83%06:57 EDT
Volume:14.64M
Turnover:2.82B
Market Cap:78.44B
PE:-24.54
High:197.69
Open:183.65
Low:182.50
Close:187.46
52wk High:212.22
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.87
T/O Rate:3.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:11.60
PE(LYR):-27.06

Loading ...

Movement Alert|Moderna, Inc. Rises 3.04% in Regular Trading, Cancer Vaccine Phase 3 Success and Analyst Upgrades Continue to Drive Momentum

Market Focus
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 22

Forge Nano and Nanexa to Develop Gmp-Compatible Ald Manufacturing Equipment

Reuters
·
Sep 22

Nanexa, Forge Nano Enter Joint Development Deal on GMP-Scale ALD Equipment for PharmaShell Injectables

Reuters
·
Sep 22

Moderna Surges 12% to a New 52-Week High as Phase 3 Cancer Vaccine Data Set for October Release

Bellwether Stocks Movement
·
Sep 22

Moderna Inc. Stock Climbs 12.3%, Outperforms Peers

Dow Jones
·
Sep 22

Moderna Provides Details on Data Presentations at Upcoming Conferences

MT Newswires Live
·
Sep 22

Why Is Moderna Stock (MRNA) Soaring Today, September 21?

TIPRANKS
·
Sep 22

Moderna Inc Stock (MRNA) Moved Up by 14.21% on Sep 21: Drivers Behind the Movement

TradingKey
·
Sep 22

Moderna Stock Jumps. Its mRNA Cancer Vaccine is Getting Ready for Its Next Big Test.

Dow Jones
·
Sep 22

Moderna to Present Late-Breaking Phase 3 Melanoma Data for Intismeran Autogene at ESMO 2026

Reuters
·
Sep 22

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 22

Moderna announces late-breaking data to be presented at ESMO Congress 2026

TIPRANKS
·
Sep 21

Movement Alert|Moderna, Inc. Rises 4.67% in Regular Trading, Cancer Vaccine Phase 3 Success and Institutional Upgrades Continue to Drive Momentum

Market Focus
·
Sep 21

Movement Alert|Moderna, Inc. Rises 3.03% in Pre-Market Trading, Cancer Vaccine Phase 3 Success and Analyst Upgrades Continue to Fuel Rally

Market Focus
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Sep 21

Movement Alert|Moderna, Inc. Falls 4.38% in Regular Trading, Trading at $153.105

Market Focus
·
Sep 19

Cboe data shows mixed options sentiment in Moderna with shares down 1.49%

TIPRANKS
·
Sep 18

LIVE Markets-Cash-Return Stocks Win Back Investor Favor, Leaving Megacaps Behind

Reuters
·
Sep 18

Moderna stock rises 8%: can it continue its cancer vaccine success rally?

Bellwether Stocks Movement
·
Sep 18